Crescent Biopharma Is A Biotechnology Company Dedicated To Developing Precision Engineered Therapies For Solid Tumorsthe Company Focuses On Creating Novel Molecules That Target Validated Cancer Biology To Enhance Treatment Outcomescrescent Aims To Deliver Best In Class Therapies By Utilizing Proven Scientific Mechanisms And Accelerating Clinical Development Timelinesits Pipeline Includes Innovative Products Such As Cr 001A Bispecific Antibody Designed For Immuno Oncologyand Two Antibody Drug Conjugatescr 002 And Cr 003 The Leadership Team At Crescent Biopharma Includes Experienced Professionals In The Biotech Fieldsuch As Ceo Joshua Brumm And President And Coo Jonathan Mcneillm Dthe Company Is Also Preparing For A Reverse Merger With Glycomimeticsexpected To Close In Q2 2025Crescent S Mission Is To Advance Next Generation Cancer Therapies Through Validated Biological Pathwayswith A Strong Emphasis On Rapid Clinical Translation And Operational Excellence
